Black Women's Health Study

From WikiMD's WELLNESSPEDIA


The Black Women's Health Study (BWHS) is a long-term epidemiological study that investigates the health of African American women. Established in 1995, the study is one of the largest and most comprehensive research projects focusing on the health of Black women in the United States. It is conducted by researchers at the Boston University and the Slone Epidemiology Center.

History[edit]

The Black Women's Health Study was initiated in response to the lack of data on the health of African American women, who have historically been underrepresented in medical research. The study began with over 59,000 participants who were recruited through Essence magazine, a publication with a predominantly African American female readership.

Objectives[edit]

The primary objectives of the BWHS are to:

Methodology[edit]

Participants in the BWHS complete biennial questionnaires that collect data on a wide range of health-related topics, including:

  • Medical history and diagnoses
  • Lifestyle factors such as diet, exercise, and smoking
  • Reproductive history
  • Use of medications and supplements

The study employs a cohort study design, allowing researchers to follow participants over time and assess changes in health status and risk factors.

Key Findings[edit]

The BWHS has contributed significantly to the understanding of health disparities affecting Black women. Some key findings include:

  • A higher incidence of breast cancer in Black women under the age of 45 compared to their white counterparts.
  • The identification of specific risk factors for hypertension and type 2 diabetes in Black women.
  • Insights into the impact of racism and stress on health outcomes.

Impact[edit]

The findings from the BWHS have informed public health policies and interventions aimed at reducing health disparities. The study has also raised awareness about the unique health challenges faced by Black women and has highlighted the importance of including diverse populations in medical research.

See also[edit]

External links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.